跳至主要内容
临床试验/DRKS00032881
DRKS00032881已完成不适用

Observational cohort study of pregnancy outcomes after intrauterine exposure to clindamycin based on the Embryotox cohort

Pharmakovigilanz- und Beratungszentrum für Embryonaltoxikologie0 个研究点目标入组 400 人开始时间: 2024年1月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
one 至 one(—)
性别
Female

入选标准

  • For study cohorts: Enrollment of pregnancies, of which neither the outcome nor pathological results of prenatal diagnostics are known at the first contact. First contact with the Embryotox Center of Clinical Teratology and Drug Safety in Pregnancy, Berlin during the study period 01.01.2000- 31.07.2023. Information on the outcome of pregnancy is completed. The quality of the information/data must comply with internal standards.

排除标准

  • Exclusion criteria (applies for the exposed cohort and the control cohorts):
  • -Malignant diseases
  • -Exposure to proven teratogens [acenocoumarol, carbamazepine, lenalidomide, methotrexate, mycophenolate, phenobarbital, phenprocoumon, phenytoin, retinoids (acitretin, adapalene, alitretinoin, isotretinoin, tazarotene, tretinoin, trifarotene), topimarate, thalidomide, valproic acid, warfarin]; Exposure to fetotoxic substances in the second and/or third trimester [angiotensin converting enzyme (ACE) inhibitors, angiotensin II receptor antagonists]
  • -Topical/cutaneous application of clindamycin (exception: vaginal application)
  • -Indication for clindamycin treatment due to pathological pregnancy complications (e.g. preterm labour, premature rupture of membranes) caused by infection in late pregnancy
  • -Insufficient data on pregnancy outcome or non-plausible, missing relevant data

研究者

发起方
Pharmakovigilanz- und Beratungszentrum für Embryonaltoxikologie

相似试验

未知
不适用
A study to evaluate pregnancy outcome and to establish a registration database of pregnant women with preexisting diabetes and Overt diabetes in pregnancy:a multicenter, prospective study -Diabetes and Pregnancy Outcome for Mother and Baby Study,DM and Overt DM-Pregnant Outcome study[DREAMBee study,DM/OvertDM-PO]preexisting diabetes Overt diabetes in pregnancy
JPRN-UMIN000024373The Japanese Society of Dianetes and Pregnancy135
招募中
不适用
A study to evaluate pregnancy outcome and to establish a registration database of pregnant women with preexisting diabetes and gestational diabetes mellitus(GDM) :a multicenter, prospective study -Diabetes and Pregnancy Outcome for Mother and Baby Study,GDM-Pregnant Outcome study[DREAMBee study,GDM-PO]Gestational diabetes mellitus(GDM)
JPRN-UMIN000023420The Japanese Society of Dianetes and Pregnancy1,800
招募中
不适用
zwangerschapsuitkomsten bij vrouwen met een erfelijke stollingsziektevon Willebrand diseasehemophilia carrierpost partum hemorrhage (PPH)
NL-OMON23871niversity Medical Center Utrecht135
招募中
不适用
Investigation of pregnancy outcomes among mothers with gestational diabetes using mobile application-assisted remote patient monitoringGestational Diabetes Mellitus.O24.4Gestational diabetes mellitus
IRCT20170515033984N2Shahid Beheshti University of Medical Sciences75
招募中
不适用
Predicting Adverse Pregnancy Outcomes (PAPO) Study: An observational study to determine factors in both male and female partners to predict healthy pregnancies and adverse pregnancy outcomesPregnancy ComplicationsReproductive Health and Childbirth - Fetal medicine and complications of pregnancy
ACTRN12609000254291ational Health and Medical Research Council (NHMRC)750